Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02632305
Title A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer (AX-CSARC)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors AHS Cancer Control Alberta


ampulla of Vater carcinoma

intrahepatic cholangiocarcinoma

gallbladder cancer


Cisplatin + Gemcitabine + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries CAN

No variant requirements are available.